Literature DB >> 10063270

T lymphocytes and cytokine production in ascitic fluid of ovarian malignancies.

C K Chen1, M Y Wu, K H Chao, H N Ho, B C Sheu, S C Huang.   

Abstract

The activation status of T lymphocytes and the presence of various cytokines in ascitic fluid were examined to test peritoneal immunity in women with ovarian malignancies. Peripheral blood and peritoneal fluid were collected from 12 patients with primary ovarian cancer with ascites and 27 normal control subjects during laparoscopic examination. Lymphocyte subpopulations and the expression of activation markers on T lymphocytes were analyzed by dual-color flow cytometry. The concentrations of various cytokines and soluble interleukin (IL)-2 receptor-alpha were measured. CD8 T lymphocytes were the main component of peritoneal lymphocytes. CD69 and HLA-DR, but not CD25, were highly expressed on peritoneal T lymphocytes compared to those in peripheral blood. In ascitic fluid of ovarian malignancies, CD4 T lymphocyte concentrations were further decreased, resulting in a decreased CD4/CD8 ratio. Decreased expression of CD69 and CD25 was also noted on T lymphocytes from ascites compared with T lymphocytes in normal peritoneal fluid. IL-1b, tumor necrosis factor-alpha, IL-6, and soluble IL-2 receptor-alpha concentrations were increased significantly in the ascitic fluid of women with ovarian cancer. The decrease in activation markers on T lymphocytes is suggestive of an immunosuppressive state, despite the presence of abundant stimulatory cytokines. The immunosuppression may be multifactorial, attributed, in part, to the increased concentrations of soluble IL-2 receptor-alpha and other inhibitors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10063270

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  4 in total

1.  Cancer Immunoediting: Elimination, Equilibrium, and Immune Escape in Solid Tumors.

Authors:  Jacek R Wilczyński; Marek Nowak
Journal:  Exp Suppl       Date:  2022

2.  Depressed and anxious mood and T-cell cytokine expressing populations in ovarian cancer patients.

Authors:  Susan K Lutgendorf; Donald M Lamkin; Koen DeGeest; Barrie Anderson; Minh Dao; Stephanie McGinn; Bridget Zimmerman; Heena Maiseri; Anil K Sood; David M Lubaroff
Journal:  Brain Behav Immun       Date:  2008-02-13       Impact factor: 7.217

Review 3.  Clinical Use of Interferon-gamma.

Authors:  Catriona H T Miller; Stephen G Maher; Howard A Young
Journal:  Ann N Y Acad Sci       Date:  2009-12       Impact factor: 5.691

4.  A multiplex platform for the identification of ovarian cancer biomarkers.

Authors:  Kristin L M Boylan; Kate Geschwind; Joseph S Koopmeiners; Melissa A Geller; Timothy K Starr; Amy P N Skubitz
Journal:  Clin Proteomics       Date:  2017-10-10       Impact factor: 3.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.